OnKure Therapeutics, Inc. (OKUR) Operating income 2020–2025
OnKure Therapeutics, Inc. (OKUR) annual operating income history from SEC filings — each fiscal year as reported.
-$63.0MFY2025 · since FY2020: -$19.6M → -$63.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.0M | -15.7% |
| FY2024 | -$54.4M | -47.3% |
| FY2023 | -$36.9M | +31.4% |
| FY2022 | -$53.8M | -35.2% |
| FY2021 | -$39.8M | -103.7% |
| FY2020 | -$19.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice